Entia Biosciences, Inc.
company.status.inactiveCIK 1408299fmd_1ZTJNE63MXE3C5G47APDSWZX5PManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2010 to Dec 31, 2016, 27 periods
Latest annual · FY2016
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (1)
- Net income
- (1)
- Free cash flow
- (1)
Latest quarter · Q4 FY2016
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (0)
- Net income
- (0)
- Free cash flow
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2013 to FY2016
- -5.5%
- Revenue, 5 yearsFY2011 to FY2016
- -8.0%
- Net income, 5 yearsFY2011 to FY2016
- n/m
Entia Biosciences, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2016 | FY2015 | Change | Source |
|---|---|---|---|---|
| Revenue | $265,466 | $346,910 | -23.5% | 10-K 2017-05-19 · proof |
| Gross profit | $173,967 | $215,903 | -19.4% | 10-K 2017-05-19 · proof |
| Operating income | -$1.3 million | -$2 million | 10-K 2017-05-19 · proof | |
| Net income | -$1.4 million | -$2.3 million | 10-K 2017-05-19 · proof | |
| Cash from operating activities | -$715,098 | -$536,565 | 10-K 2017-05-19 · proof | |
| Free cash flow | -$715,098 | -$544,616 | 10-K 2017-05-19 · proof | |
| Total assets | $439,141 | $448,606 | -2.1% | 10-K 2017-05-19 · proof |
| Total liabilities | $2.4 million | $1.2 million | +94% | 10-K 2017-05-19 · proof |
| Cash and cash equivalents | $76,050 | $24,133 | +215.1% | 10-K 2017-05-19 · proof |
- What was Entia Biosciences, Inc.'s revenue in fiscal 2016?
- Entia Biosciences, Inc. reported revenue of $265,466 for fiscal 2016 (the year ended Dec 31, 2016), against $346,910 the year before (-23.5%). Source: the 10-K filed with the SEC on May 19, 2017. SEC
- What was Entia Biosciences, Inc.'s gross profit in fiscal 2016?
- Entia Biosciences, Inc. reported gross profit of $173,967 for fiscal 2016 (the year ended Dec 31, 2016), against $215,903 the year before (-19.4%). Source: the 10-K filed with the SEC on May 19, 2017. SEC
- What was Entia Biosciences, Inc.'s operating income in fiscal 2016?
- Entia Biosciences, Inc. reported operating income of -$1.3 million for fiscal 2016 (the year ended Dec 31, 2016), against -$2 million the year before. Source: the 10-K filed with the SEC on May 19, 2017. SEC
- What was Entia Biosciences, Inc.'s net income in fiscal 2016?
- Entia Biosciences, Inc. reported net income of -$1.4 million for fiscal 2016 (the year ended Dec 31, 2016), against -$2.3 million the year before. Source: the 10-K filed with the SEC on May 19, 2017. SEC
- What was Entia Biosciences, Inc.'s cash from operating activities in fiscal 2016?
- Entia Biosciences, Inc. reported cash from operating activities of -$715,098 for fiscal 2016 (the year ended Dec 31, 2016), against -$536,565 the year before. Source: the 10-K filed with the SEC on May 19, 2017. SEC
- What was Entia Biosciences, Inc.'s free cash flow in fiscal 2016?
- Entia Biosciences, Inc. reported free cash flow of -$715,098 for fiscal 2016 (the year ended Dec 31, 2016), against -$544,616 the year before. Source: the 10-K filed with the SEC on May 19, 2017. SEC
- What are Entia Biosciences, Inc.'s total assets?
- As of Dec 31, 2016, Entia Biosciences, Inc. reported total assets of $439,141, against $448,606 a year earlier (-2.1%). Source: the 10-K filed with the SEC on May 19, 2017. SEC
- What are Entia Biosciences, Inc.'s total liabilities?
- As of Dec 31, 2016, Entia Biosciences, Inc. reported total liabilities of $2.4 million, against $1.2 million a year earlier (+94%). Source: the 10-K filed with the SEC on May 19, 2017. SEC
- What are Entia Biosciences, Inc.'s cash and cash equivalents?
- As of Dec 31, 2016, Entia Biosciences, Inc. reported cash and cash equivalents of $76,050, against $24,133 a year earlier (+215.1%). Source: the 10-K filed with the SEC on May 19, 2017. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1408299&period_type=annual&limit=5"Information only, not investment advice.